Philadelphia, PANCT04487249Now EnrollingIRB Ready

Intermittent Exotropia Clinical Trial in Philadelphia, PA

Access cutting-edge intermittent exotropia treatment through this clinical trial at a research site in Philadelphia. Study-provided care at no cost to qualified participants.

Sponsored by Southern California College of Optometry at Marshall B. Ketchum University

Quick Self-Assessment

See if you qualify for this Philadelphia location

Preparing your pre-screening questions…

Expert Care in Philadelphia

Access intermittent exotropia specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related intermittent exotropia treatment provided free

Apply for This Philadelphia Location

Check if you qualify for this intermittent exotropia clinical trial in Philadelphia, PA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Philadelphia

    Convenient for PA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Philadelphia site if eligible
  4. 4Begin participation

About This Intermittent Exotropia Study in Philadelphia

The main objective of this randomized trial comparing vision therapy to observation is to determine the short-term effectiveness of vision therapy on distance intermittent exotropia control. The results will help determine whether to proceed to a full-scale, long-term randomized trial.

Sponsor: Southern California College of Optometry at Marshall B. Ketchum University

Who Can Participate

Inclusion Criteria

Age 8 - 16 years
Intermittent exotropia meeting all of the following:
Distance exodeviation of 15∆ to 35∆ by prism alternating cover test (PACT)
IXT, exophoria, or orthophoria at near
Near exodeviation that does not exceed the distance exodeviation by more than 10∆
Mean distance control score of 2 points or more with at least one measure being 3 points or higher
Mean near control score less than 5 points
Random dot stereopsis of 200" or better on Preschool Randot Stereotest
Willingness to accept randomization and no plan to relocate in the next 6 months Major

Exclusion Criteria

Treatment for IXT or amblyopia (other than refractive correction) within 3 months prior to enrollment
Office-based vision therapy for IXT within 6 months prior to enrollment
Prior office-based vision therapy for IXT of ≥10 sessions
Prior strabismus, intraocular, or refractive surgery (including BOTOX injection)

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Philadelphia?

Yes, this clinical trial (NCT04487249) has an active research site in Philadelphia, PA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Intermittent Exotropia Treatment Options in Philadelphia, PA

If you're searching for intermittent exotropia treatment options in Philadelphia, PA, this clinical trial (NCT04487249) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Philadelphia research site is actively enrolling participants for this clinical trial. You'll receive care from experienced intermittent exotropia specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all intermittent exotropia clinical trials near you to find additional studies recruiting in your area.

More Heart Attack Trials in Philadelphia, PA

See all heart attack clinical trials recruiting in Philadelphia — not just this study.

Browse Heart Attack Trials in Philadelphia

Ready to Join in Philadelphia?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Philadelphia, PA